- Home
- VLYPO vs BRTX Comparison
VLYPO vs BRTX Comparison
Compare VLYPO & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
VLYPO
Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B
Current Price
Company Overview
Basic Information| Metric | VLYPO | BRTX |
|---|---|---|
| Founded | N/A | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Managed Health Care |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 7.1M |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VLYPO | BRTX |
|---|---|---|
| Price | $24.85 | $0.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.4K | ★ 334.7K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.38 | N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | N/A | $298.39 |
| Revenue Next Year | N/A | $64.62 |
| P/E Ratio | $43.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.10 | $0.16 |
| 52 Week High | $25.59 | $1.89 |
Technical Indicators
Market Signals| Indicator | VLYPO | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 38.15 |
| Support Level | $24.54 | $0.23 |
| Resistance Level | $25.05 | $0.31 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 25.48 | 38.45 |
Price Performance
Historical ComparisonAbout VLYPO Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.